Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Journal of Translational Medicine|September 22, 2014
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitorTakumi Kumai, Kensuke Oikawa, Naoko Aoki, et al.
Chemical & Pharmaceutical Bulletin|September 4, 2023
Facile Preparation of L-Iduronic Acid and α-L-Iduronidation Using Methyl 1,2,3,4-Tetra-O-acetyl-α-L-iduronate as Glycosyl DonorTetsuya Kajimoto, Tianqi Du, Tenchi Yoshitake, et al.
Journal of Medical Case Reports|June 30, 2022
An infantile case of hereditary folate malabsorption with sudden development of pulmonary hemorrhage: a case reportYukari Sakurai, Naohisa Toriumi, Takeo Sarashina, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2005
Defining MHC class II T helper epitopes for WT1 tumor antigenHiroya Kobayashi, Toshihiro Nagato, Naoko Aoki, et al.
The Journal of Urology|March 23, 2010
Six-transmembrane epithelial antigen of the prostate as an immunotherapeutic target for renal cell and bladder cancerMakoto Azumi, Hiroya Kobayashi, Naoko Aoki, et al.
Cancer Immunology Research|December 13, 2016
Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell ResponsesTakumi Kumai, Sujin Lee, Hyun-Il Cho, et al.
Journal of Leukocyte Biology|December 17, 2008
Expression and functional role of MDL-1 (CLEC5A) in mouse myeloid lineage cellsNaoko Aoki, Yuka Kimura, Shoji Kimura, et al.
International Journal of Cancer|December 10, 2022
Celecoxib promotes the efficacy of STING-targeted therapy by increasing antitumor CD8+ T-cell functions via modulating glucose metabolism of CD11b+ Ly6G+ cellsAkemi Kosaka, Yuki Yajima, Shunsuke Yasuda, et al.
Immunopharmacology and Immunotoxicology|April 6, 2017
Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivoHiroshi Azuma, Yoichiro Yoshida, Hironori Takahashi, et al.
Cancer Immunology, Immunotherapy : CII|May 29, 2012
A naturally processed HLA-DR-bound peptide from the IL-9 receptor alpha of HTLV-1-transformed T cells serves as a T helper epitopeHiroya Kobayashi, Takumi Kumai, Satoshi Hayashi, et al.
Pageof 10